Dermama Bioteknologi Laboratorium
1 clinical trials · Sponsor
◉ Watch Dermama Bioteknologi Laboratorium
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of EXOSOME-MSC Therapy to Reduce Hyper-inflammation In Moderate COVID-19 Patients (NCT05216562) | Dermama Bioteknologi Laboratorium | 2021-07-01 |
Track Dermama Bioteknologi Laboratorium automatically
Every clearance here is in the API, with alerts when new ones post.